Asensus Surgical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-31: Reporting owner Starling William N JR; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-31: Reporting owner HSIAO JANE PH D; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-31: Reporting owner Biffi Andrea; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-12-31: Reporting owner LAVIOLETTE PAUL A; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | Starling William N JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,756 14,756 owned after | $0.63 exercise price | 2021-01-05 | |
| 2020-12-31 | HSIAO JANE PH D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,831 12,831 owned after | $0.63 exercise price | 2021-01-05 | |
| 2020-12-31 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,831 12,831 owned after | $0.63 exercise price | 2021-01-05 | |
| 2020-12-31 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,323 34,323 owned after | $0.63 exercise price | 2021-01-05 | |
| 2020-09-30 | Starling William N JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,852 14,852 owned after | $0.35 exercise price | 2020-10-02 | |
| 2020-09-30 | HSIAO JANE PH D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,915 12,915 owned after | $0.35 exercise price | 2020-10-02 | |
| 2020-09-30 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,915 12,915 owned after | $0.35 exercise price | 2020-10-02 | |
| 2020-09-30 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,548 34,548 owned after | $0.35 exercise price | 2020-10-02 | |
| 2020-08-24 | Shameze Rampertab Officer (EVP, Chief Financial Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.42 exercise price | 2020-08-25 | |
| 2020-06-08 | HSIAO JANE PH D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,250 31,250 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,313 7,313 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +62,500 62,500 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,250 31,250 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | Milne David Bruce Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,250 31,250 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | Fernando Anthony C. J. Director, Officer (President and CEO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +550,000 550,000 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | PFENNIGER RICHARD C JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,250 31,250 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | Farabaugh Brett Officer (Interim CFO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $0.82 exercise price | 2020-06-10 | |
| 2020-06-08 | Starling William N JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,250 31,250 owned after | $0.82 exercise price | 2020-06-10 |